Pharmaceutical companies in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Johnson & Johnson has the lowest figure of the 44 pharmaceutical companies in the United States ranked by short interest, at 0.71%, followed by Eli Lilly (0.81%) and AbbVie (0.89%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
44
Lowest
Johnson & Johnson0.71%
Median
7.16%
Combined market value
$3.81T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Pharmaceutical companies in the United States by short interest
#CompanyShort interest % ↑Market capPriceToday1 yearPrice, 30 daysCountry
1Johnson & JohnsonJNJ · Health Care0.71%$656.5B$272.70 2.15% down 34% up United States
2Eli LillyLLY · Health Care0.81%$1.23T$1,382.75 2.32% down 33% up United States
3AbbVieABBV · Health Care0.89%$505.6B$286.01 2.33% down 25% up United States
4Merck & CoMRK · Health Care1.08%$339.7B$137.78 3.90% down 45% up United States
5Abbott LaboratoriesABT · Health Care1.10%$181B$104.48 0.22% down 16% down United States
6Vertex PharmaceuticalsVRTX · Health Care1.90%$136B$536.45 0.42% up 27% up United States
7Regeneron PharmaceuticalsREGN · Health Care2.14%$97.8B$945.53 1.28% down 28% up United States
8Royalty PharmaRPRX · Health Care2.27%$39.5B$68.67 0.01% down 79% up United States
9Bristol-Myers SquibbBMY · Health Care2.29%$121.7B$59.56 2.92% down 30% up United States
10PfizerPFE · Health Care2.36%$159.9B$28.06 1.44% down 15% up United States
11ViatrisVTRS · Health Care3.07%$23.3B$20.28 0.83% down 99% up United States
12Amneal PharmaceuticalsAMRX · Health Care3.27%$7.6B$21.88 3.60% up 90% up United States
13Belite BioBLTE · Health Care3.40%$6.3B$156.23 0.94% down 43% up United States
14Alnylam PharmaceuticalsALNY · Health Care4.08%$20B$149.40 4.54% down 66% down United States
15ZoetisZTS · Health Care4.12%$34.8B$85.57 2.50% up 26% down United States
16United TherapeuticsUTHR · Health Care4.31%$24.6B$577.34 1.16% down 22% up United States
17Summit TherapeuticsSMMT · Health Care5.28%$8.4B$10.50 1.59% down 36% down United States
18Legend BiotechLEGN · Health Care6.13%$3.2B$16.25 0.87% up 41% down United States
19Axsome TherapeuticsAXSM · Health Care6.20%$7B$134.00 1.43% down 6% down United States
20InsmedINSM · Health Care6.42%$26.3B$119.80 1.69% down 40% down United States
21Elanco Animal HealthELAN · Health Care6.59%$13.3B$26.70 3.29% up 26% up United States
22Definium TherapeuticsDFTX · Health Care7.02%$4B$29.12 0.88% down 168% up United States
23BioMarin PharmaceuticalBMRN · Health Care7.29%$11.9B$61.43 4.99% up 17% up United States
24VeradermicsMANE · Health Care8.03%$5.3B$124.86 0.62% down 231% up United States
25Arrowhead PharmaceuticalsARWR · Health Care8.19%$6.1B$43.11 0.28% up 13% up United States
26Corcept TherapeuticsCORT · Health Care8.34%$7.4B$67.79 3.25% down 10% down United States
27Madrigal PharmaceuticalsMDGL · Health Care9.20%$9.2B$398.08 5.67% down 27% down United States
28PTC TherapeuticsPTCT · Health Care9.31%$5B$60.23 0.22% down 21% down United States
29Oruka TherapeuticsORKA · Health Care9.53%$6.5B$95.74 0.60% down 255% up United States
30Travere TherapeuticsTVTX · Health Care9.96%$4.8B$50.24 1.68% down 45% up United States
31Mirum PharmaceuticalsMIRM · Health Care9.99%$6B$92.49 0.59% up 34% up United States
32Cogent BiosciencesCOGT · Health Care10.0%$4.8B$27.81 0.14% down 20% down United States
33ErascaERAS · Health Care10.6%$4.8B$13.76 0.94% down 395% up United States
34BridgeBio PharmaBBIO · Health Care10.7%$15.2B$78.01 1.58% up 21% up United States
35Edgewise TherapeuticsEWTX · Health Care11.6%$4.5B$41.37 1.59% down 86% up United States
36Spyre TherapeuticsSYRE · Health Care12.2%$9.6B$101.46 8.15% up 332% up United States
37Ligand PharmaceuticalsLGND · Health Care12.3%$6B$298.71 1.67% up 50% up United States
38Ionis PharmaceuticalsIONS · Health Care12.7%$4.6B$27.39 1.59% up 63% down United States
39CytokineticsCYTK · Health Care12.9%$7.1B$51.32 0.64% down 19% down United States
40Praxis Precision MedicinesPRAX · Health Care15.1%$8.5B$305.19 0.04% up 86% up United States
41Protagonist TherapeuticsPTGX · Health Care15.7%$8.3B$127.16 2.00% up 51% up United States
42Dianthus TherapeuticsDNTH · Health Care16.5%$4.7B$83.98 3.45% down 108% up United States
43Rhythm PharmaceuticalsRYTM · Health Care16.8%$8.3B$119.04 2.08% up 18% up United States
44TG TherapeuticsTGTX · Health Care19.0%$10B$66.12 5.44% up 117% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further.

Questions and answers

Which pharmaceutical companies in the United States have the lowest short interest?

Johnson & Johnson (0.71%), Eli Lilly (0.81%) and AbbVie (0.89%) have the lowest short interest of the 44 pharmaceutical companies in the United States ranked here as of the 30 Oct 2026 settlement date.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by short interest.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by short interest have a combined market value of $3.81T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.